Access the New ISN Toolkit on Optimizing SGLT2i Therapy and a Brand New Tool on MRAs
The Optimization of SGLT2i Therapy Toolkit* is the latest educational offering from a multi-society cardio-kidney-metabolic initiative led by the ISN. This initiative offers resources for advancing the prevention and management of cardio-kidney-metabolic complications. The toolkit highlights the crucial role of SGLT2 inhibitors in improving outcomes for patients with both kidney and cardiovascular diseases. The SGLT2i...